DrugPatentWatch Database Preview
Email this page to a colleague» See Plans and Pricing
« Back to Dashboard
Elvucitabine is an investigational drug.
There have been 6 clinical trials for Elvucitabine. The most recent clinical trial was a Phase 2 trial, which was initiated on April 1st 2006.
The most common disease conditions in clinical trials are HIV Infections, Acquired Immunodeficiency Syndrome, and Immunologic Deficiency Syndromes. The leading clinical trial sponsors are Achillion Pharmaceuticals, Incyte Corporation, and Orlando Immunology Center.
Recent Clinical Trials for Elvucitabine
|An Open Label Treatment Protocol to Provide Continued Elvucitabine Treatment||Bellos, Nicholaos C., M.D.||Phase 2|
|An Open Label Treatment Protocol to Provide Continued Elvucitabine Treatment||Center for the Prevention and Treatment of Infections||Phase 2|
|An Open Label Treatment Protocol to Provide Continued Elvucitabine Treatment||Central Texas Primary Care Research Network||Phase 2|